GlassScriptPhysician profile
Edward C Adler
NPI 1780645564
$1,760.42
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,328 · 2020: $201 · 2021: $231.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $558.15 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $273.46 | 2019 | |
| Janssen Biotech, INC. | $228.63 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $213.81 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $119.81 | 2019 | |
| Celgene Corporation | $118.02 | 2021 | |
| Shire North American Group INC | $100.00 | 2019 | |
| Merck Sharp & Dohme LLC | $49.76 | 2019 | |
| Gilead Sciences, INC. | $37.71 | 2019 | |
| Daiichi Sankyo INC. | $16.03 | 2019 | |
| Shionogi INC | $14.86 | 2019 | |
| Romark Laboratories, Lc | $13.44 | 2019 | |
| Intercept Pharmaceuticals, INC. | $10.83 | 2019 | |
| Dynavax Technologies Corporation | $5.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.